Treatment outcomes of patients with Atopic Dermatitis (AD) treated with dupilumab through the Early Access to Medicines Scheme (EAMS) in the UK

por O’Kane, D, Davis, L, Ardern-Jones, M, Laws, P, Shaw, L, Cork, M, Velangi, S, Cooper, HL, Hudson, R, Smith, AB, Rout, R
Publicado 2021